# Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System

> **NCT00973362** · PHASE3 · COMPLETED · sponsor: **Gen-Probe, Incorporated** · enrollment: 12896 (actual)

## Conditions studied

- Human Papillomavirus Infection

## Interventions

- **DEVICE:** APTIMA HPV Assay
- **DEVICE:** FDA-Approved HPV DNA Test

## Key facts

- **NCT ID:** NCT00973362
- **Lead sponsor:** Gen-Probe, Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2013-06
- **Final completion:** 2014-04
- **Target enrollment:** 12896 (ACTUAL)
- **Last updated:** 2017-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00973362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00973362, "Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00973362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*